Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma. | Front Oncol | 2022 | 35912172 | PubTator, text mining | PubMed |
| The Immunological Synapse: An Emerging Target for Immune Evasion by Bacterial Pathogens. | Front Immunol | 2022 | 35911720 | PubTator, text mining | PubMed |
| Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial. | Diabetes Care | 2022 | 35894933 | PubTator, text mining | PubMed |
| Is the HTLV-1 Retrovirus Targeted by Host Restriction Factors? | Viruses | 2022 | 35893677 | PubTator, text mining | PubMed |
| The Multi-Omics Landscape and Clinical Relevance of the Immunological Signature of Phagocytosis Regulators: Implications for Risk Classification and Frontline Therapies in Skin Cutaneous Melanoma. | Cancers (Basel) | 2022 | 35892841 | PubTator, text mining | PubMed |
| Immune-Related Genomic Schizophrenic Subtyping Identified in DLPFC Transcriptome. | Genes (Basel) | 2022 | 35885983 | PubTator, text mining | PubMed |
| PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas. | Biomedicines | 2022 | 35884893 | PubTator, text mining | PubMed |
| TP53 and LRP1B Co-Wild Predicts Improved Survival for Patients with LUSC Receiving Anti-PD-L1 Immunotherapy. | Cancers (Basel) | 2022 | 35884443 | PubTator, text mining | PubMed |
| IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer. | Proc Natl Acad Sci U S A | 2022 | 35878022 | PubTator, text mining | PubMed |
| Pathogenic Variants in Cardiomyopathy Disorder Genes Underlie Pediatric Myocarditis-Further Impact of Heterozygous Immune Disorder Gene Variants? | J Cardiovasc Dev Dis | 2022 | 35877578 | PubTator, text mining | PubMed |
| Dengue Infection - Recent Advances in Disease Pathogenesis in the Era of COVID-19. | Front Immunol | 2022 | 35874775 | PubTator, text mining | PubMed |
| Latitudinal and longitudinal regulation of tissue macrophages in inflammatory diseases. | Genes Dis | 2022 | 35873033 | PubTator, text mining | PubMed |
| Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma. | Nat Commun | 2022 | 35869073 | PubTator, text mining | PubMed |
| Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses. | J Clin Invest | 2022 | 35852856 | PubTator, text mining | PubMed |
| A CMV-induced adaptive human Vδ1+ γδ T cell clone recognizes HLA-DR. | J Exp Med | 2022 | 35852466 | PubTator, text mining | PubMed |
| Offense and Defense in Granulomatous Inflammation Disease. | Front Cell Infect Microbiol | 2022 | 35846773 | PubTator, text mining | PubMed |
| SARS-CoV-2-Induced Immunosuppression: A Molecular Mimicry Syndrome. | Glob Med Genet | 2022 | 35846107 | PubTator, text mining | PubMed |
| Narrative review of the relationship between the maternal-fetal interface immune tolerance and the onset of preeclampsia. | Ann Transl Med | 2022 | 35845477 | PubTator, text mining | PubMed |
| Dominant Myocardial Fibrosis and Complex Immune Microenvironment Jointly Shape the Pathogenesis of Arrhythmogenic Right Ventricular Cardiomyopathy. | Front Cardiovasc Med | 2022 | 35845067 | PubTator, text mining | PubMed |
| Identification of Key Non-coding RNAs and Transcription Factors in Calcific Aortic Valve Disease. | Front Cardiovasc Med | 2022 | 35845040 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=36